Bristol Revises Product Overstocking Impact With $262 Mil. Medicaid Accrual

Bristol-Myers Squibb is increasing its estimate of the impact of wholesaler overstocking by $262 mil. to reflect an adjustment to the amount it has set aside for Medicaid rebate payments

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet